Attached files
file | filename |
---|---|
EX-21 - EXHIBIT 21 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex21.htm |
EXCEL - IDEA: XBRL DOCUMENT - BRAINSTORM CELL THERAPEUTICS INC. | Financial_Report.xls |
EX-31.2 - EXHIBIT 31.2 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex31-2.htm |
EX-23.1 - EXHIBIT 23.1 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex23-1.htm |
EX-32.2 - EXHIBIT 32.2 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex32-2.htm |
EX-32.1 - EXHIBIT 32.1 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex32-1.htm |
EX-31.1 - EXHIBIT 31.1 - BRAINSTORM CELL THERAPEUTICS INC. | v403621_ex31-1.htm |
10-K - FORM 10-K - BRAINSTORM CELL THERAPEUTICS INC. | v403621_10k.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference to Registration Statement Nos. 333-131880, 333-168763, 333-175460, 333-182546 and 333-198391 on Form S-8 and Nos. 333-201704 and 333-201705 on Form S-3 of our report dated April 13, 2008, relating to the financial statements of BRAINSTORM CELL THERAPEUTICS INC. as of December 31, 2007 and for the year ended December 31, 2007 (which report expresses an unqualified opinion and includes an explanatory paragraph regarding the Company's ability to continue as a going concern) appearing in this Annual Report on Form 10-K of BRAINSTORM CELL THERAPEUTICS INC. for the year ended December 31, 2014.
/s/ Kost Forer Gabbay & Kasierer | ||
Tel-Aviv, Israel | KOST FORER GABBAY & KASIERER | |
March 26, 2015 | A Member of Ernst & Young Global |